A civilization is not destroyed by wicked people; it is not necessary that people be wicked but only that they be spineless." - James Baldwin
Today, we take an in-depth look at a 'Busted IPO' whose stock has behaved better of late. This concern has several important trial milestones on the horizon. A full analysis follows in the paragraphs below.
Company Overview
Kezar Life Sciences, Inc. (KZR) is a South San Francisco-based clinical-stage biotechnology concern focused on developing therapeutics to treat autoimmune diseases. The company has one asset in the clinic, KZR-616, which is being